Financial

Cyclarity Therapeutics Announces Clinical Advisory Board

NOVATO, Calif, Oct. 17, 2023 (GLOBE NEWSWIRE) — Cyclarity Therapeutics, Inc. (https://cyclaritytx.com), today announced its newly formed Clinical Advisory Board to guide its clinical development of drug candidate UDP-003 for the treatment and prevention of atherosclerosis, primary coronary artery disease, and associated cardiovascular diseases. The Board includes the internationally recognized, […]

Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range

ABBOTT PARK, Ill., Oct. 18, 2023 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2023. Third-quarter GAAP diluted EPS of $0.82 and adjusted diluted EPS of $1.14, which excludes specified items. Abbott narrowed its full-year 2023 EPS guidance range. Abbott projects full-year diluted EPS on a GAAP basis of $3.14 to $3.18 and […]

Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India

CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced a significant move to transform global cardiovascular health, by entering into a Supply and Distribution Agreement with one of India’s premier organizations, Aimil Ltd. Aimil, a company at the forefront of the instrumentation industry […]

CARMAT Completes a €7 Million Capital Increase With Several Historical Financial Shareholders

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from advanced biventricular heart failure (the “Company” or “CARMAT“), today announced the completion of a capital increase for a total amount of €7 million, subscribed in its […]

Cordis issues statement on the CMS announcement to expand coverage of carotid stenting

Miami Lakes, 10/16/2023 – Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, strongly supports the decision made by the Centers for Medicare & Medicaid Services (CMS) to expand coverage of carotid artery stenting (CAS) cms.gov. This expansion in coverage will allow patients that suffer […]

Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins

CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced the launch of the Company’s new integrated facility in Iowa City, Iowa. This facility will house Cardio Diagnostics’ new research laboratory, high-complexity Clinical Laboratory Improvement Amendments (CLIA) laboratory, and fulfillment center, serving as […]

VarmX Promotes CSO Dr. Jeffrey Lawson to New CEO and Moves to New State-of-the-Art Facility

LEIDEN, The Netherlands–(BUSINESS WIRE)–VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that Dr. Jeffrey Lawson, currently the Company’s Chief Scientific Officer, will assume the role of CEO, succeeding Dr. Jan Öhrström who will continue as Chairman. “Jeff’s extensive background as […]

Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives

GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced the promotions of neuroradiologists, Dr. Edmond Knopp and Dr. Chip Truwit. Effective immediately, Drs. Knopp and Truwit will be […]

Vektor Medical Strengthens Its Medical Advisory Board with World-renowned Leaders in Electrophysiology

SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in arrhythmia care and developer of the only FDA-cleared non-invasive technology to accurately map arrhythmias using just 12-lead ECG data, is delighted to announce the expansion of its esteemed Medical Advisory Board. The newly expanded Medical Advisory Board, features preeminent electrophysiology leaders, including: Dr. […]